Using Overlap Weights to Address Extreme Propensity Scores in Estimating Restricted Mean Counterfactual Survival Times
Authors:
Zhiqiang Cao,
Lama Ghazi,
Claudia Mastrogiacomo,
Laura Forastiere,
F. Perry Wilson,
Fan Li
Abstract:
While the inverse probability of treatment weighting (IPTW) is a commonly used approach for treatment comparisons in observational data, the resulting estimates may be subject to bias and excessively large variance when there is lack of overlap in the propensity score distributions. By smoothly down-weighting the units with extreme propensity scores, overlap weighting (OW) can help mitigate the bi…
▽ More
While the inverse probability of treatment weighting (IPTW) is a commonly used approach for treatment comparisons in observational data, the resulting estimates may be subject to bias and excessively large variance when there is lack of overlap in the propensity score distributions. By smoothly down-weighting the units with extreme propensity scores, overlap weighting (OW) can help mitigate the bias and variance issues associated with IPTW. Although theoretical and simulation results have supported the use of OW with continuous and binary outcomes, its performance with right-censored survival outcomes remains to be further investigated, especially when the target estimand is defined based on the restricted mean survival time (RMST)-a clinically meaningful summary measure free of the proportional hazards assumption. In this article, we combine propensity score weighting and inverse probability of censoring weighting to estimate the restricted mean counterfactual survival times, and propose computationally-efficient variance estimators. We conduct simulations to compare the performance of IPTW, trimming, and OW in terms of bias, variance, and 95% confidence interval coverage, under various degrees of covariate overlap. Regardless of overlap, we demonstrate the advantage of OW over IPTW and trimming methods in bias, variance, and coverage when the estimand is defined based on RMST.
△ Less
Submitted 10 February, 2024; v1 submitted 1 April, 2023;
originally announced April 2023.
